Published in Am J Psychiatry on December 01, 2009
Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci (2011) 5.03
Revising the borderline diagnosis for DSM-V: an alternative proposal. J Pers Disord (2010) 2.25
Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci (2010) 1.64
Mechanisms of disturbed emotion processing and social interaction in borderline personality disorder: state of knowledge and research agenda of the German Clinical Research Unit. Borderline Personal Disord Emot Dysregul (2014) 1.03
Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord (2009) 1.03
Family study of borderline personality disorder and its sectors of psychopathology. Arch Gen Psychiatry (2011) 0.95
Etiological features of borderline personality related characteristics in a birth cohort of 12-year-old children. Dev Psychopathol (2012) 0.95
COMT val158met polymorphism and neural pain processing. PLoS One (2012) 0.88
A developmental neuroscience of borderline pathology: emotion dysregulation and social baseline theory. J Abnorm Child Psychol (2012) 0.88
Nonsuicidal self-injury as a predictor of suicidal behavior in depressed adolescents. Am J Psychiatry (2011) 0.88
Social cognition in borderline personality disorder. Front Neurosci (2013) 0.84
Childhood aggression, callous-unemotional traits and oxytocin genes. Eur Child Adolesc Psychiatry (2012) 0.84
Oxytocin in the socioemotional brain: implications for psychiatric disorders. Dialogues Clin Neurosci (2015) 0.82
Consistency and coherence in treatment outcome measures for borderline personality disorder. Borderline Personal Disord Emot Dysregul (2015) 0.81
Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder. Psychiatry Res (2014) 0.79
Affective behavior during mother-daughter conflict and borderline personality disorder severity across adolescence. Personal Disord (2014) 0.79
The use of prescription opioid medication by patients with borderline personality disorder and axis II comparison subjects: a 10-year follow-up study. J Clin Psychiatry (2014) 0.78
Fear conditioning induced by interpersonal conflicts in healthy individuals. PLoS One (2015) 0.78
Examining the association of NRXN3 SNPs with borderline personality disorder phenotypes in heroin dependent cases and socio-economically disadvantaged controls. Drug Alcohol Depend (2012) 0.77
Facial trust appraisal negatively biased in borderline personality disorder. Psychiatry Res (2013) 0.77
Borderline Personality Disorder: Why 'fast and furious'? Evol Med Public Health (2016) 0.77
Borderline personality disorder: current drug treatments and future prospects. Ther Adv Chronic Dis (2010) 0.76
Anger and aggression in borderline personality disorder and attention deficit hyperactivity disorder - does stress matter? Borderline Personal Disord Emot Dysregul (2017) 0.75
Testing the social competition hypothesis of depression using a simple economic game. BJPsych Open (2016) 0.75
Psychopharmacologic treatment of borderline personality disorder. Dialogues Clin Neurosci (2013) 0.75
A negative relationship between ventral striatal loss anticipation response and impulsivity in borderline personality disorder. Neuroimage Clin (2016) 0.75
Diagnosing and managing violence. Prim Care Companion CNS Disord (2011) 0.75
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling. Front Behav Neurosci (2016) 0.75
Brief report: Borderline personality symptoms and perceived caregiver criticism in adolescents. J Adolesc (2015) 0.75
Reinventing intention: 'self-harm' and the 'cry for help' in postwar Britain. Curr Opin Psychiatry (2012) 0.75
Lower Oxytocin Plasma Levels in Borderline Patients with Unresolved Attachment Representations. Front Hum Neurosci (2016) 0.75
Affiliative and prosocial motives and emotions in mental health. Dialogues Clin Neurosci (2015) 0.75
Computational Psychiatry in Borderline Personality Disorder. Curr Behav Neurosci Rep (2017) 0.75
Pain affect encoded in human anterior cingulate but not somatosensory cortex. Science (1997) 5.96
Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry (2006) 5.92
Oxytocin, vasopressin, and the neurogenetics of sociality. Science (2008) 5.53
Why does social exclusion hurt? The relationship between social and physical pain. Psychol Bull (2005) 5.11
Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry (2003) 4.94
COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science (2003) 4.72
Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry (2006) 4.71
Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci U S A (1998) 4.67
Neuroendocrine perspectives on social attachment and love. Psychoneuroendocrinology (1998) 4.56
Oxytocin improves "mind-reading" in humans. Biol Psychiatry (2006) 4.56
The rupture and repair of cooperation in borderline personality disorder. Science (2008) 4.33
Evaluating three treatments for borderline personality disorder: a multiwave study. Am J Psychiatry (2007) 4.23
Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature (2004) 4.00
Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem (2005) 3.53
Microsatellite instability generates diversity in brain and sociobehavioral traits. Science (2005) 3.43
A role for central vasopressin in pair bonding in monogamous prairie voles. Nature (1993) 3.42
Linking antisocial behavior, substance use, and personality: an integrative quantitative model of the adult externalizing spectrum. J Abnorm Psychol (2007) 3.42
Genetic variation in the vasopressin receptor 1a gene (AVPR1A) associates with pair-bonding behavior in humans. Proc Natl Acad Sci U S A (2008) 2.97
Neurobiology of aggression and violence. Am J Psychiatry (2008) 2.78
Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol Pharmacol (1993) 2.54
Endogenous opioids: biology and function. Annu Rev Neurosci (1984) 2.54
8-year follow-up of patients treated for borderline personality disorder: mentalization-based treatment versus treatment as usual. Am J Psychiatry (2008) 2.50
Evidence for a neuroendocrinological foundation of human affiliation: plasma oxytocin levels across pregnancy and the postpartum period predict mother-infant bonding. Psychol Sci (2007) 2.45
Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci (2008) 2.41
Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry (2003) 2.31
Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proc Natl Acad Sci U S A (2005) 2.29
Profound impairment in social recognition and reduction in anxiety-like behavior in vasopressin V1a receptor knockout mice. Neuropsychopharmacology (2004) 2.26
The neuroscience of affiliation: forging links between basic and clinical research on neuropeptides and social behavior. Horm Behav (2006) 2.10
Vasopressin: behavioral roles of an "original" neuropeptide. Prog Neurobiol (2007) 2.04
Is social attachment an addictive disorder? Physiol Behav (2003) 2.01
Variations in maternal behaviour are associated with differences in oxytocin receptor levels in the rat. J Neuroendocrinol (2000) 2.00
Oxytocin enhances the encoding of positive social memories in humans. Biol Psychiatry (2008) 1.90
Regulation of human affective responses by anterior cingulate and limbic mu-opioid neurotransmission. Arch Gen Psychiatry (2003) 1.89
Lower CSF oxytocin concentrations in women with a history of childhood abuse. Mol Psychiatry (2008) 1.82
Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res (1998) 1.80
Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79
Neural correlates of antinociception in borderline personality disorder. Arch Gen Psychiatry (2006) 1.78
The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor. J Neurochem (2007) 1.78
mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci (2002) 1.77
A psychobiological perspective on the personality disorders. Am J Psychiatry (1991) 1.76
Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact. Psychosom Med (2005) 1.74
Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci (1997) 1.72
Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. Prog Brain Res (2008) 1.71
Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry (2008) 1.70
Confirmatory factor analysis of DSM-IV criteria for borderline personality disorder: findings from the collaborative longitudinal personality disorders study. Am J Psychiatry (2002) 1.66
Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness. Horm Behav (2009) 1.65
Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study. Biol Psychiatry (2001) 1.62
The neurobiology of love. FEBS Lett (2007) 1.61
The oxytocin receptor (OXTR) contributes to prosocial fund allocations in the dictator game and the social value orientations task. PLoS One (2009) 1.58
Variation at the mu-opioid receptor gene (OPRM1) influences attachment behavior in infant primates. Proc Natl Acad Sci U S A (2008) 1.56
Evidence for a dysfunctional prefrontal circuit in patients with an impulsive aggressive disorder. Proc Natl Acad Sci U S A (2002) 1.51
Vasopressin, oxytocin and social behaviour. Curr Opin Neurobiol (2004) 1.46
Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J Endocrinol (1975) 1.43
The biology of social attachments: opiates alleviate separation distress. Biol Psychiatry (1978) 1.42
CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers. Arch Gen Psychiatry (1994) 1.41
Central vasopressin and oxytocin release: regulation of complex social behaviours. Prog Brain Res (2008) 1.41
BPD's interpersonal hypersensitivity phenotype: a gene-environment-developmental model. J Pers Disord (2008) 1.39
Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res (1998) 1.35
The effects of vasopressin on human facial responses related to social communication. Psychoneuroendocrinology (2004) 1.31
Sensitivity to intranasal oxytocin in adult men with early parental separation. Biol Psychiatry (2006) 1.30
Clinical review: Vasopressin and terlipressin in septic shock patients. Crit Care (2004) 1.30
Disturbed relationships as a phenotype for borderline personality disorder. Am J Psychiatry (2007) 1.28
Effects of early life stress on adult male aggression and hypothalamic vasopressin and serotonin. Eur J Neurosci (2006) 1.27
Emotion dysregulation and the development of borderline personality disorder. Dev Psychopathol (2005) 1.27
Endogenous opioids and social behavior. Neurosci Biobehav Rev (1980) 1.27
Arginine vasopressin and oxytocin modulate human social behavior. Ann N Y Acad Sci (2009) 1.24
High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol Biochem Behav (1994) 1.23
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry (2002) 1.22
Self-mutilation in personality disorders: psychological and biological correlates. Am J Psychiatry (1992) 1.22
Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress. Psychophysiology (2008) 1.21
Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience (2004) 1.18
Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res (2009) 1.18
Mechanisms underlying epigenetic effects of early social experience: the role of neuropeptides and steroids. Neurosci Biobehav Rev (2005) 1.17
Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry (1998) 1.15
Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2. Eur J Pharmacol (2007) 1.15
Aversive tension in patients with borderline personality disorder: a computer-based controlled field study. Acta Psychiatr Scand (2005) 1.14
Interpersonal precipitants and suicide attempts in borderline personality disorder. Suicide Life Threat Behav (2006) 1.14
AVPR1A and OXTR polymorphisms are associated with sexual and reproductive behavioral phenotypes in humans. Mutation in brief no. 981. Online. Hum Mutat (2007) 1.13
The development of borderline personality disorder--a mentalizing model. J Pers Disord (2008) 1.13
The role of CRF in behavioral aspects of stress. Ann N Y Acad Sci (1995) 1.13
Opiate modulation of separation-induced distress in non-human primates. Brain Res (1988) 1.12
Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior. Psychiatry Res (2000) 1.09
The physiology and neurochemistry of self-injurious behavior: a nonhuman primate model. Front Biosci (2005) 1.08
Paternal behavior influences development of aggression and vasopressin expression in male California mouse offspring. Horm Behav (2006) 1.08
Are the interpersonal and identity disturbances in the borderline personality disorder criteria linked to the traits of affective instability and impulsivity? J Pers Disord (2001) 1.07
Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder. Psychiatry Res (2006) 1.04
Pain perception in self-injurious patients with borderline personality disorder. Biol Psychiatry (1992) 1.03
Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord (2009) 1.03
The essential nature of borderline psychopathology. J Pers Disord (2007) 1.03
The nature of borderline personality disorder: multiple dimensions, multiple symptoms, but one category. J Pers Disord (2007) 1.02
Self-injurious behavior and mood regulation in borderline patients. J Pers Disord (1997) 1.00
Raised plasma metenkephalin in patients who habitually mutilate themselves. Lancet (1983) 0.99
The Personality Disorders Institute/Borderline Personality Disorder Research Foundation randomized control trial for borderline personality disorder: rationale, methods, and patient characteristics. J Pers Disord (2004) 0.99
Borderline personality as a self-other representational disturbance. J Pers Disord (2007) 0.99
Suckling-induced attenuation of plasma cortisol concentrations in postpartum lactating women. Endocr Res (1994) 0.98
Vasopressin mediates enhanced offspring protection in multiparous rats. Neuropharmacology (2009) 0.97
Neuropeptides and social behavior: animal models relevant to autism. Mol Psychiatry (2002) 0.97
Association between arginine vasopressin 1a receptor (AVPR1a) promoter region polymorphisms and prepulse inhibition. Psychoneuroendocrinology (2009) 0.96
Neuroendocrine mechanisms of stress and social interaction: implications for mental disorders. Curr Opin Psychiatry (2007) 0.95
Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch Gen Psychiatry (2007) 2.91
The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry (2002) 2.75
Characterizing affective instability in borderline personality disorder. Am J Psychiatry (2002) 2.44
Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl) (2004) 2.06
Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2011) 1.93
The Consortium on the Genetics of Endophenotypes in Schizophrenia: model recruitment, assessment, and endophenotyping methods for a multisite collaboration. Schizophr Bull (2006) 1.88
The borderline diagnosis II: biology, genetics, and clinical course. Biol Psychiatry (2002) 1.81
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide. Biol Psychiatry (2004) 1.71
Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology (2007) 1.54
Abuse and neglect in childhood: relationship to personality disorder diagnoses. CNS Spectr (2003) 1.38
Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res (2007) 1.36
Neural correlates of using distancing to regulate emotional responses to social situations. Neuropsychologia (2010) 1.33
Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder. J Psychiatr Res (2009) 1.32
Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry (2013) 1.30
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part I: Description and rationale. Personal Disord (2011) 1.30
Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr Res (2008) 1.29
Personality disorder types proposed for DSM-5. J Pers Disord (2011) 1.27
Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity. Biol Psychiatry (2002) 1.27
Successful multi-site measurement of antisaccade performance deficits in schizophrenia. Schizophr Res (2006) 1.25
Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry (2005) 1.23
Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am J Psychiatry (2005) 1.22
Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch Gen Psychiatry (2002) 1.22
Neural correlates of the use of psychological distancing to regulate responses to negative social cues: a study of patients with borderline personality disorder. Biol Psychiatry (2009) 1.21
Abnormal auditory N100 amplitude: a heritable endophenotype in first-degree relatives of schizophrenia probands. Biol Psychiatry (2008) 1.19
Neural correlates of emotion processing in borderline personality disorder. Psychiatry Res (2009) 1.18
The relationship of borderline personality disorder to posttraumatic stress disorder and traumatic events. Am J Psychiatry (2003) 1.17
Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am J Psychiatry (2005) 1.17
Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol Psychiatry (2009) 1.17
Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry (2011) 1.12
Context-processing deficits in schizotypal personality disorder. J Abnorm Psychol (2004) 1.12
Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophr Res (2007) 1.11
Exaggerated affect-modulated startle during unpleasant stimuli in borderline personality disorder. Biol Psychiatry (2007) 1.11
Affective lability and affect intensity as core dimensions of bipolar disorders during euthymic period. Psychiatry Res (2008) 1.10
Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression. Psychopharmacology (Berl) (2004) 1.07
Cortical gray and white matter volume in unmedicated schizotypal and schizophrenia patients. Schizophr Res (2008) 1.07
Context processing in schizotypal personality disorder: evidence of specificity of impairment to the schizophrenia spectrum. J Abnorm Psychol (2008) 1.07
Potentiated amygdala response to repeated emotional pictures in borderline personality disorder. Biol Psychiatry (2012) 1.06
Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res (2007) 1.05
Cingulate gyrus volume and metabolism in the schizophrenia spectrum. Schizophr Res (2004) 1.05
Deficient attentional modulation of the startle response in patients with schizotypal personality disorder. Am J Psychiatry (2003) 1.04
Differential metabolic rates in prefrontal and temporal Brodmann areas in schizophrenia and schizotypal personality disorder. Schizophr Res (2002) 1.04
Risperidone in the treatment of schizotypal personality disorder. J Clin Psychiatry (2003) 1.03
A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Arch Gen Psychiatry (2012) 1.02
The role of childhood trauma in differences in affective instability in those with personality disorders. CNS Spectr (2003) 1.00
24-h Monitoring of plasma norepinephrine, MHPG, cortisol, growth hormone and prolactin in depression. J Psychiatr Res (2004) 1.00
Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res (2010) 0.99
Group and site differences on the California Verbal Learning Test in persons with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia (COGS). Schizophr Res (2011) 0.97
Antisaccade performance in schizophrenia patients, their first-degree biological relatives, and community comparison subjects: data from the COGS study. Psychophysiology (2010) 0.96
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia. J Neurochem (2003) 0.96
The effects of guanfacine on context processing abnormalities in schizotypal personality disorder. Biol Psychiatry (2006) 0.95
Frontal-striatal-thalamic mediodorsal nucleus dysfunction in schizophrenia-spectrum patients during sensorimotor gating. Neuroimage (2008) 0.95
Recent advances in the biological study of personality disorders. Psychiatr Clin North Am (2008) 0.93
Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res (2009) 0.93
Proposed changes in personality and personality disorder assessment and diagnosis for DSM-5 Part II: Clinical application. Personal Disord (2011) 0.92
Neurobiologic function and temperament in subjects with personality disorders. CNS Spectr (2003) 0.92
Dispositional impulsivity in normal and abnormal samples. J Psychiatr Res (2006) 0.91
Impairment in functional capacity as an endophenotype candidate in severe mental illness. Schizophr Bull (2011) 0.91
Pergolide treatment of cognitive deficits associated with schizotypal personality disorder: continued evidence of the importance of the dopamine system in the schizophrenia spectrum. Neuropsychopharmacology (2010) 0.89
Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol Psychiatry (2010) 0.89
Empathy and alexithymia in borderline personality disorder: clinical and laboratory measures. J Pers Disord (2012) 0.88
Deficient attentional modulation of startle eyeblink is associated with symptom severity in the schizophrenia spectrum. Schizophr Res (2007) 0.88
Sex differences in familiality effects on neurocognitive performance in schizophrenia. Biol Psychiatry (2013) 0.88
Low prolactin response to fenfluramine in impulsive aggression. J Psychiatr Res (2004) 0.88
Childhood trauma and basal cortisol in people with personality disorders. Compr Psychiatry (2008) 0.87
Fine mapping of the 5p13 locus linked to schizophrenia and schizotypal personality disorder in a Puerto Rican family. Psychiatr Genet (2005) 0.86
Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia. Neuropsychopharmacology (2012) 0.85
The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572. Am J Med Genet B Neuropsychiatr Genet (2014) 0.85
Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J Psychiatr Res (2010) 0.84
Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups. Psychiatr Genet (2006) 0.84
The neural correlates of anomalous habituation to negative emotional pictures in borderline and avoidant personality disorder patients. Am J Psychiatry (2014) 0.84
Prefrontal dopamine D1 receptors and working memory in schizotypal personality disorder: a PET study with [¹¹C]NNC112. Psychopharmacology (Berl) (2014) 0.84
Serotonin 2c receptor RNA editing in major depression and suicide. World J Biol Psychiatry (2012) 0.84
Platelet protein kinase C and brain-derived neurotrophic factor levels in borderline personality disorder patients. Psychiatry Res (2012) 0.84
Schizoid personality disorder. J Pers Disord (2012) 0.83
The neurobiology of empathy in borderline personality disorder. Curr Psychiatry Rep (2013) 0.83
Cingulate and temporal lobe fractional anisotropy in schizotypal personality disorder. Neuroimage (2011) 0.82
CACNA1C as a risk factor for schizotypal personality disorder and schizotypy in healthy individuals. Psychiatry Res (2012) 0.82
Anterior and posterior cingulate cortex volume in healthy adults: effects of aging and gender differences. Brain Res (2011) 0.82
Functional MRI of visuospatial working memory in schizotypal personality disorder: a region-of-interest analysis. Psychol Med (2005) 0.82
Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder. Behav Brain Res (2010) 0.81
Irritable assault and variation in the COMT gene. Psychiatr Genet (2007) 0.81
Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder. Schizophr Res (2004) 0.81
Anterior limb of the internal capsule in schizotypal personality disorder: fiber-tract counting, volume, and anisotropy. Schizophr Res (2012) 0.81
Dual-task information processing in schizotypal personality disorder: evidence of impaired processing capacity. Neuropsychology (2006) 0.81
Striatal activity in borderline personality disorder with comorbid intermittent explosive disorder: sex differences. J Psychiatr Res (2012) 0.80
Reduced processing resource availability in schizotypal personality disorder: evidence from a dual-task CPT study. J Clin Exp Neuropsychol (2003) 0.80
Functional outcomes, functional capacity, and cognitive impairment in schizotypal personality disorder. Schizophr Res (2013) 0.79
Neurocognitive performance in family-based and case-control studies of schizophrenia. Schizophr Res (2015) 0.79
Psychometric properties of a short form of the Affective Lability Scale (ALS-18). Pers Individ Dif (2010) 0.79
Catechol-O-methyltransferase Val158Met genotype in healthy and personality disorder individuals: Preliminary results from an examination of cognitive tests hypothetically differentially sensitive to dopamine functions. Neuropsychiatr Dis Treat (2007) 0.79
Schizotypal personality disorder: a current review. Curr Psychiatry Rep (2014) 0.79
Deficient visual sensitivity in schizotypal personality disorder. Schizophr Res (2010) 0.78
Empathic accuracy and cognition in schizotypal personality disorder. Psychiatry Res (2013) 0.78
Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum. Arch Clin Neuropsychol (2006) 0.78
Genetic variations in the ADAMTS12 gene are associated with schizophrenia in Puerto Rican patients of Spanish descent. Neuromolecular Med (2012) 0.78
Conflict of interest-- an issue for every psychiatrist. Am J Psychiatry (2009) 0.77
Eye tracking performance and the boundaries of the schizophrenia spectrum. Psychiatry Res (2010) 0.77
Growth hormone response to guanfacine in boys with attention deficit hyperactivity disorder: a preliminary study. J Child Adolesc Psychopharmacol (2003) 0.77
Joint Effect of Childhood Abuse and Family History of Major Depressive Disorder on Rates of PTSD in People with Personality Disorders. Depress Res Treat (2012) 0.77
Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder. Schizophr Res (2012) 0.77